Menu
Not yet recruiting NCT06832735

Health-related Quality of Life of Women with Polycystic Ovary Syndrome At Sohag University Hospital

Observational Polycystic Ovary Syndrome (PCOS) Women

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Polycystic Ovary Syndrome (PCOS) Women. Basic parameters: 18 years — 45 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

It is well-established that PCOS women suffer from anxiety, depression, and markedly reduced QoL ,but There has not yet been a nationally representative study to evaluate the PCOS health related Qol and factors affecting it among women in Egypt. So here we try to cover this gap in this study that will be designed to record the QOL of women with PCOS and factors affecting it. This study aims to assess the health related quality of life of polycystic ovary syndrome and determine factors affecting the HRQOL

Primary outcome measures

  • health related quality of life of women with PCOS [Time frame: 2 months after answering the polycystic ovary syndrome questionnaire]
Secondary outcome measures (1)
  • Factors affecting health related quality of life of women with PCOS [Time frame: 2 months after collecting data from the medical chart]

Eligibility criteria

Inclusion criteria

  • • Female cases between 18 and 45.
  • Females diagnosed with PCOS per Rotterdam criteria , the most commonly accepted and used for PCOS, a diagnosis is confirmed if any two of the three features (hyperandrogenism, oligomenorrhea or anovulation, and polycystic ovaries) are present in a woman of reproductive age

Exclusion criteria

  • • Females below 18 years old.
  • Females above 45 years old.
  • Patients having major life event or problem also affecting quality of life.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

Egypt · 1 center
  • faculty of medicine Sohag university — Sohag

Identifiers

NCT: NCT06832735 · Soh-Med-25-2--3MD

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗